Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Reznik

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Cancer Discovery|August 4, 2021
Chemerin Tips the Scales in ccRCC to Evade FerroptosisEd Reznik, Hui Jiang, A Ari Hakimi
Nature Cancer|April 18, 2025
UnitedMet harnesses RNA-metabolite covariation to impute metabolite levels in clinical samplesAmy X Xie, Wesley Tansey, Ed Reznik
Chaos (Woodbury, N.Y.)|April 6, 2013
The dynamics of hybrid metabolic-genetic oscillatorsEd Reznik, Tasso J Kaper, Daniel Segrè
Nature Medicine|January 2, 2026
Mechanistic insights make cancer cachexia a targetable syndromeEd Reznik, Martin H Voss, A Ari Hakimi
Trends in Cancer|August 30, 2022
Mitochondrial DNA is a major source of driver mutations in cancerMinsoo Kim, Mahnoor Mahmood, Ed Reznik, et al.
Nature Reviews. Urology|July 31, 2025
Biomarkers for renal cell carcinoma - a pragmatic approachZiad Bakouny, A Ari Hakimi, Ed Reznik, et al.
Ebiomedicine|June 26, 2024
PAK4-targeted PROTACs in clear cell renal cell carcinoma: a two-for-one targeted and immune therapy?Ziad Bakouny, David A Braun, Ed Reznik, et al.
Elife|January 19, 2017
Mitochondrial respiratory gene expression is suppressed in many cancersEd Reznik, Qingguo Wang, Konnor La, et al.
Urologic Oncology|June 4, 2019
Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinomaRenzo G DiNatale, Alejandro Sanchez, A Ari Hakimi, et al.
Genome Biology|May 25, 2016
Mapping the landscape of metabolic goals of a cellQi Zhao, Arion I Stettner, Ed Reznik, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Cancer Discovery|August 4, 2021
Chemerin Tips the Scales in ccRCC to Evade FerroptosisEd Reznik, Hui Jiang, A Ari Hakimi
Nature Cancer|April 18, 2025
UnitedMet harnesses RNA-metabolite covariation to impute metabolite levels in clinical samplesAmy X Xie, Wesley Tansey, Ed Reznik
Chaos (Woodbury, N.Y.)|April 6, 2013
The dynamics of hybrid metabolic-genetic oscillatorsEd Reznik, Tasso J Kaper, Daniel Segrè
Nature Medicine|January 2, 2026
Mechanistic insights make cancer cachexia a targetable syndromeEd Reznik, Martin H Voss, A Ari Hakimi
Trends in Cancer|August 30, 2022
Mitochondrial DNA is a major source of driver mutations in cancerMinsoo Kim, Mahnoor Mahmood, Ed Reznik, et al.
Nature Reviews. Urology|July 31, 2025
Biomarkers for renal cell carcinoma - a pragmatic approachZiad Bakouny, A Ari Hakimi, Ed Reznik, et al.
Ebiomedicine|June 26, 2024
PAK4-targeted PROTACs in clear cell renal cell carcinoma: a two-for-one targeted and immune therapy?Ziad Bakouny, David A Braun, Ed Reznik, et al.
Elife|January 19, 2017
Mitochondrial respiratory gene expression is suppressed in many cancersEd Reznik, Qingguo Wang, Konnor La, et al.
Urologic Oncology|June 4, 2019
Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinomaRenzo G DiNatale, Alejandro Sanchez, A Ari Hakimi, et al.
Genome Biology|May 25, 2016
Mapping the landscape of metabolic goals of a cellQi Zhao, Arion I Stettner, Ed Reznik, et al.
Pageof 11